In agreement with previous data on end-stage HF [27], we found that a decreased BAX/BCL-2 ratio in hearts with severely impaired contractility was mainly due to increased levels of the survival factor Bcl-2. The gene discussed is BCL2; the disease is hydrops fetalis.